(C3RY) Cherry - Ratings and Ratios

Cherry SE is a German-based company that specializes in the manufacture and sale of computer input devices, catering to a diverse range of sectors including office, gaming, healthcare, security, and IoT. The companys product portfolio encompasses keyboards, mice, desktop sets, and other peripherals, as well as software solutions. With a distribution network that includes various channels such as distributors, resellers, and e-tailers, Cherry SE has established a significant presence in the technology hardware market.

From a technical analysis perspective, Cherry AGs stock (C3RY) has shown fluctuations in recent times. The current price of €1.02 is above its 20-day and 50-day Simple Moving Averages (SMA) of €0.89 and €0.83, respectively, indicating a potential uptrend. However, the stock is below its 200-day SMA of €1.05, suggesting that the long-term trend is still uncertain. The Average True Range (ATR) of 0.08 represents a 7.51% volatility, indicating moderate price swings.

Fundamentally, Cherry SE operates in the Technology Hardware, Storage & Peripherals sub-industry, with a market capitalization of €21.84M. The absence of a Price-to-Earnings (P/E) ratio and a negative Return on Equity (RoE) of -109.85% raises concerns about the companys profitability. However, its essential to consider that the company might be investing heavily in growth initiatives or restructuring, which could impact short-term profitability.

Based on the available technical and fundamental data, a forecast for Cherry AGs stock can be made. Considering the stocks current price is above its short-term SMAs and the ATR indicates moderate volatility, a potential price target could be around €1.20-€1.30 in the short term, representing a 15-20% increase from current levels. However, the absence of a P/E ratio and negative RoE suggest that the companys financial performance needs to improve to sustain long-term growth. If Cherry SE can address its profitability concerns, the stock might be poised for a more significant rebound, potentially targeting the 52-week high of €2.74. Conversely, if the company fails to improve its financials, the stock might revisit its 52-week low of €0.52.